The European Association for Haemophilia and Allied Disorders and the European Haemophilia Consortium (EHC) published today a joint statement calling on the importance of home delivery of treatment during the COVID-19 pandemic so that patients avoid frequent hospital visits. The statement also highlights the importance of preparedness for any disruptions in the treatment supply chain.